Bio-Rad Laboratories FY 2020: revenue $2.5B; diluted EPS $126.20

Key figures from this report

These are the numbers Bio-Rad Laboratories reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$2.5BNo year-earlier figure tagged10-K income statement, on EDGAR
2. Net income$3.8BNo year-earlier figure tagged10-K income statement, on EDGAR
3. Diluted EPS$126.20No year-earlier figure tagged10-K income statement, on EDGAR
4. Cash and cash equivalents$662.2MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations$575.3MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables